Comparison of Intravitreal Bevacizumab Injection with Combination of Suprachoroidal Triamcinolone Acetonide Along with Intravitreal Bevacizumab Injection in the Treatment of Diabetic Macular Edema in Pseudophakic Patients

Comparison of Intravitreal Bevacizumab Injection with Combination of Suprachoroidal Triamcinolone Acetonide Along with Intravitreal Bevacizumab Injection in the Treatment of Diabetic Macular Edema in Pseudophakic Patients

Patients were included in the study who were pseudophakic with center-involved (sub-foveal) diabetic macular edema

Patients were included in the study who were pseudophakic with center-involved (sub-foveal) diabetic macular edema. Those patients who had glaucoma history or IOP above 21 mm of Hg, Phakic, corneal opacity, vitreous hemorrhage, proliferative diabetic retinopathy, already received anti-VEGF injections, history of pan-retinal photocoagulation for proliferative diabetic retinopathy.

Inclusion Criteria:

• Patients with center involving diabetic macular edema on optical coherence tomography

Exclusion Criteria:

• Raised intraocular pressure
• History of glaucoma
• Corneal opacity
• Vitreous hemorrhage
• Proliferative diabetic retinopathy
• Anti-VEGF injections in last 3 months
• History of pan-retinal photocoagulation
• Contraindications for anti-VEGF